Trial intelligence / Profile preview

Risperdal Consta vs Oral Risperidone in First-episode Schizophrenia

NCT00330551Phase 4Completed

Sponsor
University of California, Los Angeles
Start
Mar 2006
Primary completion
Nov 2012
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of risperidone in schizophrenia, sponsored by University of California, Los Angeles. Started Mar 2006; status: completed.

02

Drugs

risperidone
03

Conditions

schizophrenia

Beyond the preview

Go deeper on NCT00330551.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00330551.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call